Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 1, 2011, Pages 390-394

  Livermore, David M ^a   Mushtaq, Shazad ^a   Warner, Marina ^a   Zhang, Jiancheng ^a   Maharjan, Sunil ^a   Doumith, Michel ^a   Woodford, Neil ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE AMPC; CARBAPENEM; CARBAPENEMASE; CEFTAZIDIME; CLAVULANIC ACID; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NXL 104; OXA 48 ENZYME; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; AZTREONAM; BACTERIAL PROTEINS; BETA-LACTAMASES; CEFTAZIDIME; DRUG COMBINATIONS; ENTEROBACTERIACEAE; MICROBIAL SENSITIVITY TESTS;

EID: 78650636489     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00756-10     Document Type: Article

References (23)

1. Bassetti, M., E. Righi, and C. Viscoli. 2008. Novel β-lactam antibiotics and inhibitor combinations. Expert Opin. Invest. Drugs 17:285-296.
2. Carrer, A., L. Poirel, M. Yilmaz, O. A. Akan, C. Feriha, G. Cuzon, G. Matar, P. Honderlick, and P. Nordmann. 2010. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob. Agents Chemother. 54:1369-1373.
3. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial testing of bacteria that grow aerobically, 7th ed., approved standard M7-A7. 2009. Clinical and Laboratory Standards Institute, Wayne, PA.
4. 3.Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: 20th informational supplement, M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Doumith, M., M. J. Ellington, D. M. Livermore, and N. Woodford. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
6. Drawz, S. M., and R. A. Bonomo. 2010. Three decades of β-lactamase inhibitors. Clin. Microbiol. Rev. 23:160-201.
7. Ellington, M. J., J. Kistler, D. M. Livermore, and N. Woodford. 2007. Multiplex PCR for rapid detection of genes encoding acquired metallo-β- lactamases. J. Antimicrob. Chemother. 59:321-322.
8. Endimiani, A., Y. Choudhary, and R. A. Bonomo. 2009. In vitro activity of NXL104 in combination with β-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases. Antimicrob. Agents Chemother. 53: 3599-3601.
9. Kitchel, B., J. K. Rasheed, J. B. Patel, A. Srinivasan, S. Navon-Venezia, Y. Carmeli, A. Brolund, and C. G. Giske. 2009. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob. Agents Chemother. 53:3365-3370.
10. Kumarasamy, K. K., M. A. Toleman, T. R. Walsh, J. Bagaria, F. Butt, R. Balakrishnan, U. Chaudhary, M. Doumith, C. G. Giske, S. Irfan, P. Krish-nan, A. V. Kumar, S. Maharjan, S. Mushtaq, T. Noorie, D. L. Paterson, A. Pearson, C. Perry, R. Pike, B. Rao, U. Ray, J. B. Sarma, M. Sharma, E. Sheridan, M. A. Thirunarayan, J. Turton, S. Upadhyay, M. Warner, W. Welfare, D. M. Livermore, and N. Woodford. 2010. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis. 10:597-602.
11. Livermore, D. M., S. Mushtaq, M. Warner, C. Miossec, and N. Woodford. 2008. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum β-lactamases and carbapenemases. J. Antimicrob. Chemother. 62:1053-1056.
12. Livermore, D. M., and N. Woodford. 2006. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14:413-420.
13. March, A., R. Aschbacher, H. Dhanji, D. M. Livermore, A. Bottcher, F. Sleghel, S. Maggi, M. Noale, C. Larcher, and N. Woodford. 2010. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. Clin. Microbiol. Infect. 16:934-944.
14. Miriagou, V., G. Cornaglia, M. Edelstein, I. Galani, C. G. Giske, M. Gniadkowski, E. Malamou-Lada, L. Martinez-Martinez, F. Navarro, P. Nordmann, L. Peixe, S. Pournaras, G. M. Rossolini, A. Tsakris, A. Vatopoulos, and R. Canton. 2010. Acquired carbapenemases in gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect. 16:112-122.
15. Mushtaq, S., Y. Ge, and D. M. Livermore. 2004. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized β-lactamases. Antimicrob. Agents Chemother. 48:1313-1319.
16. Mushtaq, S., M. Warner, G. Williams, I. Critchley, and D. M. Livermore. 2010. Activity of chequerboard combinations of ceftaroline and NXL104 versus β-lactamase-producing Enterobacteriaceae. J. Antimicrob. Chemother. 65:1428-1432.
17. Nordmann, P., G. Cuzon, and T. Naas. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
18. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.
19. Vatopoulos, A. 2008. High rates of metallo-β-lactamase-producing Klebsiella pneumoniae in Greece-a review of the current evidence. Euro Surveill. 13:8203.
20. Woodford, N., J. W. Dallow, R. L. Hill, M. F. Palepou, R. Pike, M. E. Ward, M. Warner, and D. M. Livermore. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459.
21. Woodford, N., S. Reddy, E. J. Fagan, R. L. Hill, K. L. Hopkins, M. E. Kaufmann, J. Kistler, M. F. Palepou, R. Pike, M. E. Ward, J. Cheesbrough, and D. M. Livermore. 2007. Wide geographic spread of diverse acquired AmpC β-lactamases among Escherichia coli and Klebsiella spp. in the UK and Ireland. J. Antimicrob. Chemother. 59:102-105.
22. Woodford, N., M. E. Ward, M. E. Kaufmann, J. Turton, E. J. Fagan, D. James, A. P. Johnson, R. Pike, M. Warner, T. Cheasty, A. Pearson, S. Harry, J. B. Leach, A. Loughrey, J. A. Lowes, R. E. Warren, and D. M. Livermore. 2004. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J. Antimicrob. Chemother. 54: 735-743.
23. Woodford, N., J. Zhang, M. Warner, M. E. Kaufmann, J. Matos, A. Macdonald, D. Brudney, D. Sompolinsky, S. Navon-Venezia, and D. M. Livermore. 2008. Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. J. Antimicrob. Chemother. 62:1261-1264.